Optimizing Biofoundry Technology: Spirit Scientific Explores New Applications in Regenerative Medicine

Regenerative medicine has become a rapidly growing global industry due to its properties of promoting repair and delaying degeneration. The market size is estimated to rise from US$35.5 billion in 2024 to US$90 billion by 2030. Founded in 2015, Spirit Scientific Co., Ltd., led by Founder and Chairman Steven D Lin,MD , centers its core on "Biofoundry™" engineering. By combining pharmaceutical-grade specifications to develop BMLT® , the company has extended from high-concentration platelet growth factor extraction to diverse material applications, driving the standardization and normalization of regenerative medicine. Precision Preparation